Safety and efficacy of the COVID-19 vaccine is paramount with the regulatory pathway for the vaccine in India seeing an accelerated rolling review and interim analysis of clinical trials, said Drugs Controller General of India V.G. Somani on Friday. (Read More)
Be the first to comment